Carmignac Gestion »

Corcept Therapeutics Incorporated shares owned by Carmignac Gestion

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Carmignac Gestion from 13F filings

Historical chart of Carmignac Gestion investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Carmignac Gestion consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Carmignac Gestion

Quarter filed Position value Share count Share price at filing
2023-09-30 $704k 26k 27.25
2023-06-30 $1.0M 46k 22.25
2023-03-31 $993k 46k 21.66
2022-12-31 $1.2M 61k 20.31

More positions owned by Carmignac Gestion

Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
NVIDIA Corporation (NVDA)
S&p Global (SPGI)
Intercontinental Exchange (ICE)
Alibaba Group Holding Sponsored Ads (BABA)
Alphabet Cap Stk Cl A (GOOGL)
Baxter International (BAX)
Metropcs Communications (TMUS)
General Electric (GE)
Schlumberger Com Stk (SLB)
Humana (HUM)

View all positions for Carmignac Gestion

Top funds holding Corcept Therapeutics Incorporated

Vanguard Group
Ingalls & Snyder
Parallel Advisors
Dimensional Fund Advisors
Norden Group
Btim
Federated Investors
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Charles Schwab Investment Management
Man Group
Bank of New York Mellon
Norges Bank Investment Management
Millennium Management
Kynam Capital Management

View all funds holding Corcept Therapeutics Incorporated